Usefulness of Cardiac Troponin I as a Prognostic Marker in Non-cardiac Critically Ill Patients

被引:2
作者
Kim, Hwi Jong [1 ]
Ham, Hyoun Seok [1 ]
Cho, Yu Ji [1 ]
Kim, Ho Cheol [1 ]
Lee, Jong Deok [1 ]
Hwang, Young Sil [1 ]
机构
[1] Gyeongsang Natl Univ, Coll Med, Dept Internal Med, 92 Chilam Dong, Jinju 660751, South Korea
关键词
Cardiac troponin I; Prognostic marker; Critically ill; Noncardiac patients;
D O I
10.4046/trd.2005.59.1.53
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background : Cardiac troponin I (cTnI) is a specific marker of myocardial injury. It is known that a higher level of cTnI is associated with a poor clinical outcome in patients with acute coronary syndrome. An elevation in cTnI is also observed in various noncardiac critical illnesses. This study evaluated whether cTnI is useful for predicting the prognosis in noncardiac critically ill patients. Methods : From June 2003 to July 2004 at Gyeongsang National University Hospital, we enrolled 215 patients (male: 142, female: 73, mean age: 63 +/- 15 years) who were admitted for critical illness other than acute coronary syndrome at the medical intensive care unit(ICU). The severity score of critical illness (SAPS. and SOFA) was determined and serum cTnI level was measured within 24 hours after admission to the ICU. The mortality rate was compared between the cTnI-positive (>= 0.1 mu g/L) and cTnI-negative (cTnI<0.1 mu g/L) patients at the 10th and 30th day after admission to the ICU. The mean cTnI value was compared between the survivors and non-survivors at the 10th and 30th day after admission to the ICU in the cTnI-positive patients. The correlation between cTnI and the severity of the critical illness score (SAPS. and SOFA) was also analyzed in cTnI-positive patients. Results : 1) The number of cTnI-negative and positive patients were 95(44%) and 120(56%), respectively. 2) The mortality rate at the 10 th and 30 th day after admission to the ICU was significantly higher in the cTnI-positive patients (29%, 41%) than in the cTnI-negative patients (12%, 21%)(p<0.01). 3) In the cTnI-positive patients, the mean value of the cTnI at the 10 th and 30 th day after admission to the ICU was significantly higher in the non-survivors (4.5 +/- 9.2 mu g/L, 3.5 +/- 7.9 mu g/L) than in the survivors(1.8 +/- 3.6 mu g/L, 2.0 +/- 3.9 mu g/L) (p < 0.05). 4) In the cTnI-positive patients, the cTnI level was significantly correlated with the SAPS. score (r=0.24, p<0.001) and SOFA score (r=0.30, p<0.001). Conclusion : The cTnI may be a useful prognostic marker in noncardiac critically ill patients.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 38 条
  • [1] Elevation of troponin I in sepsis and septic shock
    Ammann, P
    Fehr, T
    Minder, EI
    Günter, C
    Bertel, O
    [J]. INTENSIVE CARE MEDICINE, 2001, 27 (06) : 965 - 969
  • [2] Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes
    Ammann, P
    Maggiorini, M
    Bertel, O
    Haenseler, E
    Joller-Jemelka, HI
    Oechslin, E
    Minder, EI
    Rickli, H
    Fehr, T
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) : 2004 - 2009
  • [3] Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
    Antman, EM
    Tanasijevic, MJ
    Thompson, B
    Schactman, M
    McCabe, CH
    Cannon, CP
    Fischer, GA
    Fung, AY
    Thompson, C
    Wybenga, D
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) : 1342 - 1349
  • [4] Reversible myocardial dysfunction in critically ill, noncardiac patients:: A review
    Bailén, MR
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (06) : 1280 - 1290
  • [5] Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease
    Baillard, C
    Boussarsar, M
    Fosse, JP
    Girou, E
    Le Toumelin, P
    Cracco, C
    Jaber, S
    Cohen, Y
    Brochard, L
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (04) : 584 - 589
  • [6] Release kinetics of serum cardiac troponin I in ischemic myocardial injury
    Bertinchant, JP
    Larue, C
    Pernel, I
    Ledermann, B
    FabbroPeray, P
    Beck, L
    Calzolari, C
    Trinquier, S
    Nigond, J
    Pau, B
    [J]. CLINICAL BIOCHEMISTRY, 1996, 29 (06) : 587 - 594
  • [7] ANALYSIS OF INDICATIONS FOR EARLY DISCHARGE FROM THE INTENSIVE-CARE UNIT - CLINICAL EFFICACY ASSESSMENT PROJECT - AMERICAN-COLLEGE OF PHYSICIANS
    BONE, RC
    MCELWEE, NE
    EUBANKS, DH
    GLUCK, EH
    [J]. CHEST, 1993, 104 (06) : 1812 - 1817
  • [8] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [9] Diagnostic and prognostic value of procalcitonin in patients with septic shock
    Clec'h, C
    Ferriere, F
    Karoubi, P
    Fosse, JP
    Cupa, M
    Hoang, P
    Cohen, Y
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (05) : 1166 - 1169
  • [10] Cardiac troponin: a new serum marker of myocardial injury in sepsis
    Fernandes, CJ
    Akamine, N
    Knobel, E
    [J]. INTENSIVE CARE MEDICINE, 1999, 25 (10) : 1165 - 1168